Related Experiment Video
Updated: May 5, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
56.6K
P2X7 blockade attenuates mouse liver fibrosis
Changshan Huang1, Wei Yu, Hong Cui
1Department of Hepatobiliary Surgery, Henan Provincial Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
Molecular Medicine Reports
|November 20, 2013
Summary
Inhibiting P2X7 receptors with A438079 reduced liver injury and fibrosis in mice. This suggests P2X7 blockade is a promising therapeutic strategy for treating liver damage and scarring.
Area of Science:
- Pharmacology
- Hepatology
- Immunology
Background:
- P2X7 receptor plays a key role in inflammation and tissue damage.
- Liver injury and fibrosis are significant health concerns with limited treatment options.
Purpose of the Study:
- To investigate the therapeutic potential of P2X7 inhibition in a mouse model of liver fibrosis.
- To evaluate the effect of A438079, a specific P2X7 inhibitor, on carbon tetrachloride-induced liver injury.
Main Methods:
- A mouse model of liver fibrosis was established using chronic carbon tetrachloride (CCl4) administration.
- Mice were treated with either vehicle or A438079 to assess the impact on P2X7 expression and related pathways.
- Biochemical, histopathological, and molecular analyses (Western blot, collagen deposition, NF-κB activity) were performed.
Main Results:
- CCl4 treatment led to significant liver injury, inflammation, fibrosis, and increased P2X7 expression.
- A438079 treatment markedly reduced P2X7 expression, liver damage, and inflammatory markers.
- P2X7 inhibition also decreased collagen deposition, α-smooth muscle actin, and transforming growth factor-β1 expression.
Conclusions:
- P2X7 receptor inhibition effectively attenuated liver injury and fibrosis in a preclinical model.
- Targeting P2X7 represents a potential novel therapeutic approach for managing liver diseases characterized by inflammation and fibrosis.
